Alzheimer’s disease chips away at the respiratory system in ways that go far beyond “forgetting to breathe.” As the disease advances, it damages brainstem regions that regulate breathing rhythm, weakens the muscles used for coughing and swallowing, disrupts sleep-related breathing patterns, and ultimately makes pneumonia the leading cause of death in people with end-stage Alzheimer’s. The relationship turns out to be a two-way street, too, with respiratory problems potentially accelerating Alzheimer’s pathology itself.
How the Brain Controls Breathing and Why Alzheimer’s Disrupts It
Breathing feels automatic, and it is. The rhythm of inhaling and exhaling is generated deep in the brainstem, particularly in a region called the ventral lateral medulla. Specialized neurons there fire in patterns that drive your diaphragm and chest muscles without any conscious effort. These same areas also sense carbon dioxide levels in your blood and adjust your breathing rate accordingly. When CO₂ rises, healthy brainstem circuits tell you to breathe faster and deeper to clear it out.
In Alzheimer’s disease, the hallmark protein deposits that destroy neurons in memory-related areas also build up in these brainstem breathing centers. Research in a mouse model of Alzheimer’s found substantial amyloid-beta plaque deposits in the ventral lateral medulla, and those deposits correlated with increased pauses in breathing (apneas) and impaired ability to sense and respond to changes in blood gases.1PubMed Central. Amyloid beta plaque pathology induces chemosensory deficits and increases apnoeas in the 5XFAD mouse model of Alzheimer’s disease Essentially, the same disease process that erodes memory also erodes the brain’s ability to keep breathing smooth and responsive.
One consequence is a distorted response to carbon dioxide. Studies in both rat and mouse models of Alzheimer’s have found that AD animals overreact to rising CO₂ levels while awake, breathing harder than normal healthy controls in response to the same challenge. One study recorded a roughly 26 percent increase in the respiratory drive to CO₂ during wakefulness in Alzheimer’s-model rats.2PubMed. Hypercapnic and Hypoxic Respiratory Response During Wakefulness and Sleep in a Streptozotocin Model of Alzheimer’s Disease in Rats A separate experiment in a different Alzheimer’s mouse model confirmed significantly increased respiratory responses to high CO₂.3PubMed Central. Hypoxic and Hypercapnic Responses in Transgenic Murine Model of Alzheimer’s Disease Overexpressing Human AβPP: The Effects of Pretreatment with Memantine and Rivastigmine This exaggerated sensitivity may reflect compensatory rewiring in damaged brainstem circuits, but it also signals that the breathing-control machinery is fundamentally altered.
Swallowing Problems and the Road to Aspiration Pneumonia
For most people caring for someone with Alzheimer’s, the respiratory consequences they encounter first are not about breathing itself but about swallowing. Dysphagia, the clinical term for difficulty swallowing, appears earlier in the disease course than many families expect. A systematic review found that swallowing impairments begin in the early stages of Alzheimer’s, initially affecting the oral phase of swallowing, the part where food is chewed, formed into a ball, and pushed toward the throat. As the disease progresses, problems extend to the pharyngeal phase, where food passes through the throat, and eventually include a kind of motor planning breakdown where the brain struggles to coordinate the swallowing sequence at all.4PubMed Central. Dysphagia in Alzheimer’s disease: a systematic review
When swallowing fails, food, liquid, or saliva can slip into the airway instead of the esophagus. The body’s first defense against this is coughing, but Alzheimer’s impairs that too. The cough reflex and the swallowing reflex share overlapping brainstem circuitry, and the co-occurrence of impaired coughing and impaired swallowing is a recognized problem in both Alzheimer’s and other neurodegenerative conditions.5PubMed Central. Co-ordination of cough and swallow in vivo and in silico So the person aspirates material into the lungs and cannot cough it back out effectively, setting the stage for infection.
The result is aspiration pneumonia, and it is not a minor complication. It is the most common cause of death in end-stage Alzheimer’s disease.6PubMed. Dysphagia and aspiration pneumonia in patients with Alzheimer’s disease An analysis of U.S. mortality data identified over 335,000 deaths attributed to the combination of Alzheimer’s and aspiration pneumonia.7PubMed Central. Trends in mortality in elderly patients with Alzheimer’s dementia and aspiration pneumonitis in the United States Those numbers make clear that this is not a rare endpoint. For many families, it is how Alzheimer’s disease ultimately takes a person’s life.
Weakened Respiratory Muscles
Even without swallowing problems, the physical capacity to breathe and cough declines. The muscles involved in breathing, primarily the diaphragm and the intercostal muscles between the ribs, need intact nerve signals and general physical conditioning to function well. Alzheimer’s disease erodes both. People in later stages are often sedentary, spend more time in bed, and lose overall muscle mass. On top of that, the neurodegenerative process itself appears to play a role.
A study comparing older adults with Alzheimer’s or Parkinson’s disease to age-matched healthy controls found that both groups with neurodegenerative disease had significantly lower maximum inspiratory and expiratory pressures, the standard measures of how strongly someone can breathe in and push air out.8PubMed. Neurodegenerative disorders increase decline in respiratory muscle strength in older adults This was true even though the groups were physically similar in terms of body size and chest measurements. Reduced expiratory muscle strength directly translates to weaker coughs, which circles back to the aspiration risk discussed above. A person who cannot generate a forceful cough simply cannot clear material from the airway.
Sleep Apnea and Its Tangled Relationship with Alzheimer’s
Obstructive sleep apnea, where the airway repeatedly collapses during sleep, is extremely common in people with Alzheimer’s disease. But the relationship between the two conditions is not a simple one-way street where Alzheimer’s causes sleep apnea. It goes both directions, and the mechanisms involved have become a major focus of research.
Three pathways connect obstructive sleep apnea to Alzheimer’s pathology: the repeated drops in oxygen (intermittent hypoxia), disruption of the brain’s waste-clearance system during sleep, and the fragmented sleep itself.9Current Treatment Options in Neurology. Treatment of Obstructive Sleep Apnea in patients with Alzheimer’s Disease: role of Continuous Positive Airway Pressure therapy Sleep apnea also drives autonomic nervous system dysfunction, pushing the body into a state of chronic sympathetic overactivation that raises the risk of high blood pressure, stroke, and heart failure.10PubMed Central. Sleep apnea and autonomic dysfunction in patients with dementia That cardiovascular damage, in turn, further harms the brain.
The waste-clearance angle is particularly striking. The brain’s glymphatic system, which flushes out metabolic waste products including amyloid-beta during deep sleep, appears to malfunction in untreated sleep apnea. Imaging research found that people with untreated obstructive sleep apnea showed the highest burden of fluid accumulation in brain tissue, while those who used CPAP therapy had levels similar to healthy controls.11Alzheimer’s & Dementia. Increased glymphatic fluid volume in untreated obstructive sleep apnea If sleep apnea impairs the brain’s ability to clear toxic proteins, and those toxic proteins then damage brainstem breathing centers, you get a feedback loop where each condition worsens the other.
The Vicious Cycle of Hypoxia and Amyloid Buildup
The feedback loop idea gains more support from molecular research. When brain tissue is deprived of oxygen, whether from sleep apnea, pneumonia, respiratory muscle weakness, or any other cause, it does not just passively suffer. Low oxygen actively ramps up the production of amyloid-beta, the protein that forms the plaques central to Alzheimer’s pathology. Laboratory research demonstrated that hypoxia increases the expression and activity of the enzyme that cleaves amyloid precursor protein into amyloid-beta, boosting production of the toxic fragment both in cell cultures and in living animals.12PubMed Central. Hypoxia facilitates Alzheimer’s disease pathogenesis by up-regulating BACE1 gene expression
This mechanism means that every respiratory insult a person with Alzheimer’s experiences, whether it is an episode of sleep apnea, a bout of pneumonia, or simply chronically shallow breathing from weak muscles, could be pouring fuel on the fire of the disease itself. Researchers have noted that the most common respiratory problems seen in Alzheimer’s patients (pneumonia, shortness of breath, respiratory muscle weakness, and obstructive sleep apnea) are not just consequences of the disease but may also act as contributing factors.13PubMed Central. Respiratory Dysfunction in Alzheimer’s Disease-Consequence or Underlying Cause? Applying Animal Models to the Study of Respiratory Malfunctions Untangling cause from effect here is genuinely difficult, and most of what we know comes from animal models rather than long-term human studies. But the direction of the evidence points strongly toward a self-reinforcing cycle.
Effects Beyond the Airways
Alzheimer’s may also alter the lungs themselves at a vascular level, not just the brain centers that control them. In a mouse model of Alzheimer’s disease, researchers found increased tone (constriction) in the tiny arteries of the lungs. The lung tissue showed higher levels of oxidative stress markers, inflammatory proteins, and a loss of nitric oxide, the molecule that normally relaxes blood vessels.14PubMed Central. Increased pulmonary arteriolar tone associated with lung oxidative stress and nitric oxide in a mouse model of Alzheimer’s disease Tighter pulmonary blood vessels make it harder to exchange oxygen and carbon dioxide efficiently, even if the airways and breathing muscles are functioning.
This finding is still in the early, animal-model stage, and it has not been confirmed in humans. But it challenges the assumption that Alzheimer’s is purely a brain disease. If systemic inflammation and vascular dysfunction extend to the lungs, the respiratory compromise in Alzheimer’s patients could be even more multifaceted than previously thought. It also raises the question of whether chronic lung conditions and Alzheimer’s share enough overlapping biology to reinforce each other. Research on chronic obstructive pulmonary disease (COPD) has pointed to oxidative stress, low blood oxygen, systemic inflammation, and reduced blood flow to the brain as mechanisms linking the lung condition to higher rates of cognitive impairment.15PubMed Central. Risk of dementia or cognitive impairment in COPD patients: A meta-analysis of cohort studies
Olfactory Decline as an Early Clue
One respiratory-adjacent sign of Alzheimer’s shows up long before breathing itself becomes a problem. The sense of smell relies on the olfactory pathways that pass through the entorhinal cortex, one of the earliest brain regions damaged by Alzheimer’s. People with Alzheimer’s show reduced brain activation in primary olfactory regions during odor detection tasks, and this decline begins before a clinical diagnosis is made.16PubMed Central. Odorant-induced brain activation as a function of normal aging and Alzheimer’s disease: A preliminary study While olfactory loss is not a respiratory problem in the mechanical sense, it is a dysfunction of the nasal-brain interface, and it often prompts people to wonder whether something is wrong with their nose or sinuses when the real issue is neurological. For clinicians, a disproportionate loss of smell compared to what would be expected from normal aging can serve as a red flag for early Alzheimer’s pathology.
What About Alzheimer’s Medications and the Lungs?
Families sometimes worry that cholinesterase inhibitors, the class of drugs commonly prescribed for Alzheimer’s symptoms (donepezil, rivastigmine, galantamine), could cause respiratory problems. The concern makes biochemical sense on paper: acetylcholine affects airway smooth muscle, and increasing its levels could theoretically narrow the airways in someone with asthma or COPD. However, a study tracking older adults who started cholinesterase inhibitors found no detectable increase in complications of chronic airway disease. Rates of doctor visits, emergency room trips, and hospitalizations related to airway problems were statistically no different from what would be expected without the drugs.17PubMed Central. Initiation of acetylcholinesterase inhibitors and complications of chronic airways disorders in elderly patients That does not mean the risk is zero for every individual, and people with severe asthma or very reactive airways should still be monitored. But broadly, the standard Alzheimer’s medications do not appear to meaningfully worsen lung function.
Interventions That Can Help
Given the number of pathways through which Alzheimer’s compromises breathing and airway protection, there is no single fix. But several interventions show promise for specific parts of the problem.
For sleep apnea, CPAP therapy remains the standard treatment, and the glymphatic research mentioned earlier suggests that it may do more than just improve sleep quality. People with Alzheimer’s often struggle with CPAP adherence because the mask is unfamiliar and can be distressing, but with patient support and gradual acclimation, many can tolerate it.
For swallowing and cough strength, a training approach called expiratory muscle strength training shows early promise. A case report of a patient with mixed dementia who completed this training demonstrated a 52 percent improvement in maximum expiratory pressure and a 25 percent improvement in voluntary peak cough flow, moving from below-normal values to above the lower limit of normal for their age and sex.18PubMed Central. Feasibility of expiratory muscle strength training to address oropharyngeal dysphagia in a patient living with mixed dementia: A case report A single case report is far from proof that this works for everyone, but it suggests that at least some people with dementia can still build respiratory muscle strength with structured exercise, which is encouraging because it addresses both the cough weakness and the swallowing impairment simultaneously.
For aspiration pneumonia, particularly in advanced and end-stage Alzheimer’s, the treatment approach shifts toward comfort. Pneumonia at this stage often causes significant distress, and clinical guidance emphasizes symptom management, including control of fever, pain, breathlessness, and agitation, as an appropriate goal when curative treatment is unlikely to change the disease’s trajectory.19PubMed Central. End-of-life issues in advanced dementia: Part 2: management of poor nutritional intake, dehydration, and pneumonia Families facing this situation benefit from clear conversations about goals of care, ideally well before the crisis point.
Overlooked and Understudied
One thing that stands out across the respiratory research in Alzheimer’s disease is how much of it relies on animal models rather than large human studies. The brainstem pathology work, the CO₂ sensitivity findings, and the pulmonary vascular changes have all been demonstrated primarily in mice and rats. Human data tends to come from clinical observations of advanced disease, mortality records, and small case studies. There is a gap in our understanding of exactly when and how these respiratory changes unfold in living people over the years-long course of Alzheimer’s, and whether early intervention on respiratory function could slow cognitive decline.
Part of the problem is practical. People with moderate to advanced Alzheimer’s have difficulty cooperating with standard lung function tests, which require specific breathing maneuvers performed on command. By the time respiratory problems become clinically obvious, the disease is usually so advanced that separating the effects of Alzheimer’s itself from the effects of immobility, poor nutrition, and general frailty is nearly impossible. Researchers have called for more systematic study of respiratory function across the full spectrum of Alzheimer’s stages, using methods adapted for cognitively impaired patients.13PubMed Central. Respiratory Dysfunction in Alzheimer’s Disease-Consequence or Underlying Cause? Applying Animal Models to the Study of Respiratory Malfunctions Until that work is done, we are left with a patchwork understanding: solid evidence that respiratory complications are a major driver of disability and death in Alzheimer’s, strong mechanistic clues from animal research about why, and relatively little human data connecting the dots in between.